← Leaderboards
Andrew S Levey
Tufts Medical Center
$13,346,594
Attributed
$13,965,023
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$13,965,023 · 10
By mechanism
R01$7,184,819 · 4
T32$3,681,528 · 1
U01$2,969,796 · 3
R03$110,880 · 1
R13$18,000 · 1
Top collaborators
- Michael G Shlipak5 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Michael G Shlipak$18,418,069
- Joachim H Ix$16,690,262
- Mark J Sarnak$10,155,302
- Orlando M Gutierrez$29,690,151
- Ronald D Perrone$9,263,101
Others in their field
Top investigators on “Creatinine”
- John Anthony Baron · Dartmouth College$35,357,551
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$29,672,972
- Andrew G. Bostom · Rhode Island Hospital (Providence, Ri)$29,566,740
- Robert M. Grant · J. David Gladstone Institutes$28,544,833
- Chirag R Parikh · Johns Hopkins University$25,785,384
- Christopher J Cooper · University Of Toledo Health Sci Campus$19,285,793
Research focus
CreatinineEpidemiologyRenal FunctionPost Gamma-GlobulinsChronic Kidney FailureClinical ResearchOutcomes ResearchMeasurementKidneyKidney DiseasesClinical TrialsAge RelatedSamplingGlomerular Filtration RateCardiovascular DiseasesPopulation BasedEnrollmentLongevityPlasmaCohortIohexolRisk FactorsFiltrationPublic Health Medicine (Field)
Grant awards (45)
Epidemiology, Clinical Trials and Outcomes Research In Nephrology$170,499
T32 · FY2017 · DK · contact PI
Epidemiology, Clinical Trials and Outcomes Research In Nephrology$148,592
T32 · FY2016 · DK · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$236,269
R01 · FY2015 · DK · contact PI
Estimating GFR from a Panel of Endogenous Filtration Markers (Panel eGFR)$590,430
R01 · FY2014 · DK · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$239,788
R01 · FY2014 · DK · contact PI
Epidemiology, Clinical Trials adn Outcomes Research in Nephrology$235,379
T32 · FY2014 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$153,058
R01 · FY2014 · DK · contact PI
Estimating GFR from a Panel of Endogenous Filtration Markers (Panel eGFR)$566,817
R01 · FY2013 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$396,841
R01 · FY2013 · DK · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$243,415
R01 · FY2013 · DK · contact PI
Epidemiology, Clinical Trials adn Outcomes Research in Nephrology$232,916
T32 · FY2013 · DK · contact PI
Estimating GFR from a Panel of Endogenous Filtration Markers (Panel eGFR)$707,451
R01 · FY2012 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$449,125
R01 · FY2012 · DK · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$251,028
R01 · FY2012 · DK · contact PI
Epidemiology, Clinical Trials adn Outcomes Research in Nephrology$215,235
T32 · FY2012 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$456,295
R01 · FY2011 · DK · contact PI
Effects of Age and Race on GFR Estimation in a Population-based Cohort$266,358
R01 · FY2011 · DK · contact PI
Epidemiology, Clinical Trials adn Outcomes Research in Nephrology$95,235
T32 · FY2011 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$1
U01 · FY2011 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$669,263
R01 · FY2010 · DK · contact PI
Kidney Function, Aortic Stiffness and Aging$308,991
R01 · FY2010 · DK · contact PI
Epidemiology, Clinical Trials adn Outcomes Research in Nephrology$203,073
T32 · FY2010 · DK · contact PI
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial$29,184
U01 · FY2010 · DK · contact PI
Epidemiology, Clinical Trials, and Outcomes Research$252,469
T32 · FY2009 · DK · contact PI
Epidemiology, Clinical Trials, and Outcomes Research$298,507
T32 · FY2008 · DK · contact PI
Chronic Renal Disease-Individual Patient Meta Analysis$809,162
U01 · FY2007 · DK · contact PI
Epidemiology, Clinical Trials, and Outcomes Research$286,313
T32 · FY2007 · DK · contact PI
Chronic Renal Disease-Individual Patient Meta Analysis$860,827
U01 · FY2006 · DK · contact PI
Epidemiology, Clinical Trials, and Outcomes Research$272,638
T32 · FY2006 · DK · contact PI
Chronic Renal Disease-Individual Patient Meta Analysis$865,058
U01 · FY2005 · DK
Epidemiology, Clinical Trials, and Outcomes Research$265,705
T32 · FY2005 · DK
Chronic Renal Disease-Individual Patient Meta Analysis$869,558
R01 · FY2004 · DK
Hypertension and Renal Disease in the Pakistani Populat*$37,120
R03 · FY2004 · TW
Chronic Renal Disease-Individual Patient Meta Analysis$414,218
R01 · FY2003 · DK
EPIDEMIOLOGY, CLINICAL TRIALS AND OUTCOMES RESEARCH$272,691
T32 · FY2003 · DK
Hypertension and Renal Disease in the Pakistani Populat*$37,120
R03 · FY2003 · TW
EPIDEMIOLOGY, CLINICAL TRIALS AND OUTCOMES RESEARCH$256,859
T32 · FY2002 · DK
Hypertension and Renal Disease in the Pakistani Populat*$36,640
R03 · FY2002 · TW
EPIDEMIOLOGY, CLINICAL TRIALS AND OUTCOMES RESEARCH$231,698
T32 · FY2001 · DK
CHRONIC RENAL DISEASE--INDIVIDUAL PATIENT META ANALYSIS$177,927
R01 · FY2001 · DK
MORTALITY AND MORBIDITY IN HEMODIALYSIS PATIENTS$162,711
U01 · FY2001 · DK
Clinical Epidemiology: Vascular Access for Hemodialysis$18,000
R13 · FY2001 · DK
EPIDEMIOLOGY, CLINICAL TRIALS AND OUTCOMES RESEARCH$243,719
T32 · FY2000 · DK
MORTALITY AND MORBIDITY IN HEMODIALYSIS PATIENTS$242,853
U01 · FY2000 · DK
CHRONIC RENAL DISEASE--INDIVIDUAL PATIENT META ANALYSIS$187,987
R01 · FY2000 · DK